Pub. Date : 2020
PMID : 32115517
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Objective To examine the add-on effects, compared to the existing antidiabetes treatment, of the sodium-glucose cotransporter 2 inhibitor ipragliflozin on glycemic control and the risk factors of cardiovascular disease (CVD) and chronic kidney disease (CKD) in patients with inadequately controlled type 2 diabetes. | ipragliflozin | solute carrier family 5 member 2 | Homo sapiens |